日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004

随机对照 II 期临床试验:评估两种剂量水平的安非他酮与安慰剂对女性癌症幸存者性欲的影响:NRG-CC004

Barton, Debra L; Pugh, Stephanie L; Ganz, Patricia A; Plaxe, Steven C; Koontz, Bridget F; Carter, Jeanne; Greyz-Yusupov, Natalya; Page, Seth J; Rowland, Kendrith M Jr; Balcueva, Ernie P; Nabeel, Sobia; Basil, Jack B; Hill, Matthew L; Muller, Carolyn Y; Bell, Maria C; Deshmukh, Snehal; Kachnic, Lisa A

A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222

一项关于氟维司群、依维莫司和阿那曲唑一线治疗晚期激素受体阳性乳腺癌患者的随机试验,SWOG S1222

Moore, Halle C F; Barlow, William E; Somlo, George; Gralow, Julie R; Schott, Anne F; Hayes, Daniel F; Kuhn, Peter; Hicks, James B; Welter, Lisa; Dy, Philip A; Yeon, Christina H; Conlin, Alison K; Balcueva, Ernie; Lew, Danika L; Tripathy, Debasish; Pusztai, Lajos; Hortobagyi, Gabriel N

A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy

一项针对接受辅助化疗后1至5年内自述存在认知功能障碍的女性乳腺癌幸存者的多奈哌齐研究

Lawrence, J A; Griffin, L; Balcueva, E P; Groteluschen, D L; Samuel, T A; Lesser, G J; Naughton, M J; Case, L D; Shaw, E G; Rapp, S R

Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1

普瑞巴林缓解潮热的 III 期随机、双盲、安慰剂对照评估,N07C1

Loprinzi, Charles L; Qin, Rui; Balcueva, Ernie P; Flynn, Kathleen A; Rowland, Kendrith M Jr; Graham, David L; Erwin, Nancy K; Dakhil, Shaker R; Jurgens, Donald J; Burger, Kelli N